PainAway II Acetaminophen/Aspirin/Caffeine Tablets Recalled for Failed Stability
Ultra Seal Corporation is recalling PainAway II tablets nationwide due to failed stability specifications. Testing found out-of-specification levels of Salicylic Acid, an aspirin-related compound.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class III recall involving a labeling/quality issue (failed stability specifications) with no reported illnesses or injuries. The hazard is based on out-of-specification test results rather than confirmed harm or a high-risk pathogen, placing it in the Moderate category per the rubric.
Plain-English summary
Ultra Seal Corporation is recalling PainAway II (Acetaminophen 250 mg/Aspirin 250 mg/Caffeine 65 mg) tablets distributed nationwide in the USA. The recall affects 2,484,274 tablets packaged in 2 tablets per packet within 12,000 packets per case (Material # 11161), manufactured for Respond Industries First Aid in Mason, Ohio.
The recall was initiated because stability testing revealed out-of-specification results for Salicylic Acid, an aspirin-related compound. This indicates the product did not meet required stability specifications.
Affected lot numbers include: AK-9336 (expiration 21-Oct); K9406 and AK-9407 (expiration 21-Dec); K-9860 (expiration 22-Oct); and AK-1057 (expiration 23-Feb). Consumers who have purchased this product should stop use and consult their healthcare provider if they have questions or concerns.
The recalled product
- Product
- PainAway II (Acetaminophen 250 mg/Aspirin 250 mg/Caffeine 65 mg) tablets , 2 tablets/pk, packaged in 12,000 Packets/Case, Material # 11161, Mfg. for Respond Industries First Aid, Mason, OH 45040 (Shipping Label)
- Manufacturer
- Ultra Seal Corporation
- Affected units
- 2,484,274
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (9)
- Lot #: AK-9336
- exp. date 21-Oct
- K9406
- AK-9407
- exp. date 21-Dec
- K-9860
- exp. date 22-Oct
- AK-1057
- exp. date 23-Feb
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 8 recalled by Ultra Seal Corporation under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 8 products in this recall →Related recalls
Same manufacturer · Ultra Seal Corporation
See all →- ModeratePEPTIME Energy Caffeine Tablets Recalled for cGMP Deviations
FDA (Drugs) · 2022-02-09
- ModerateExaprin Pain Reliever Tablets Recalled for cGMP Deviations
FDA (Drugs) · 2022-02-09
- ModerateLite Remfresh Melatonin Tablets Recalled for cGMP Deviations
FDA (Drugs) · 2022-02-09
- ModerateExtra Strength Un-Aspirin Acetaminophen Packets Recalled for cGMP Deviations
FDA (Drugs) · 2022-02-09
- ModerateCold Tablet with Acetaminophen Recalled for cGMP Deviations
FDA (Drugs) · 2022-02-09
Same hazard · failed stability specifications
See all →- ModerateClobazam Oral Suspension Recalled for Failed Stability Specifications
FDA (Drugs) · 2022-01-26
- ModerateAERO Tab Pain Reliever Tablets Recalled for Failed Stability Specifications
FDA (Drugs) · 2021-11-03
- LowTeligent Pharma Recalls Lidocaine Ointment for Failed Stability Specifications
FDA (Drugs) · 2021-04-21
- ModerateAvantor Recalls Potassium Phosphate Bulk Chemical for Excess Iron Content
FDA (Drugs) · 2019-12-04
- ModerateAVKARE Fexofenadine Hydrochloride Tablets Recalled for Failed Stability Specifications
FDA (Drugs) · 2019-09-18